Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

Despite a record number of large deals across the pharmaceutical and biotechnology landscape, market indicators are pointing toward a noticeable shift in the appetite for global deal-making across the industry. As the pool of high-valued assets becomes smaller, will signs point to a drastic increase in smaller deals for larger pharma companies looking to solidify their balance sheets across core therapeutic areas? How does a strong public market with a well-capitalized pool of young biotech targets that don’t need to be forced into an early buyout impact this hypothetical M&A shift? This session will feature experienced voices explaining the public perspective for a potentially active year within pharma and biotech deal-making.Moderator:<ul><li>Ori Solomon, Partner at Morrison & Foerster </li></ul>Panel speakers:<ul><li>Kimberly Nearing, Managing Director, Head of Life Sciences, Cedrus Group; Regional Leader for BayHelix's NY/NJ/PA Chapters</li><li>Andrew Gitkin, Managing Director and Co-Head of Healthcare Investment Banking, Raymond James</li><li>E. Eric Tokat, Partner Centerview Partners LLC</li><li>Philip Ross, Vice Chairman, Healthcare Investment Banking, J.P. Morgan</li></ul><hr>

Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

Sign Up

Life Sciences + Healthcare

Technology Transactions

Mergers + Acquisitions

Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate - 566877461

Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

11 Feb 2020 12:30 AM - 1:45 AM